What question did this study set out to answer?

To review the role of Kv7 channels outside the central nervous system and evaluate their potential as therapeutic targets in smooth muscle disorders.

One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders

View Full Paper

Ask AI

Bookmark

To review the role of Kv7 channels outside the central nervous system and evaluate their potential as therapeutic targets in smooth muscle disorders.
Narrative synthesis of preclinical and clinical data regarding the anticonvulsant retigabine and Kv7 channel expression across various smooth muscle tissues.
Kv7 channels actively regulate membrane potential in multiple smooth muscle systems, beyond their established role in suppressing neuronal excitability.
Activation of smooth muscle Kv7 channels presents therapeutic opportunities for treating hypertension, overactive bladder, gastrointestinal motility issues, and preterm labor.

Population

Patients with smooth muscle disorders (e.g., hypertension, bladder instability, constipation, preterm labour)

Intervention

Targeting Kv7 channels (e.g., retigabine)

Targeting Kv7 channels, traditionally used for epilepsy, presents a novel therapeutic opportunity for smooth muscle disorders including hypertension.

No takes yet. Share an insight, caveat, or question.

Supports repurposing Kv7 modulators for smooth muscle disorders; leaves open need for clinical trials.

Jepps et al. (2012) studied this question.

View Full Paper

Ask AI

Bookmark